Literature DB >> 11657917

Precedent autonomy and personal identity.

Michael Quante.   

Abstract

Debates on precedent autonomy and some forms of paternalistic interventions, which are related to questions of personal identity, are analyzed. The discussion is based on the distinction between personal identity as persistence and as biographical identity. It first is shown that categorical objections to advance directives and "Ulysses contracts" are based on false assumptions about personal identity that conflate persistence and biographical identity. Therefore, advance directives and "Ulysses contracts" are ethically acceptable tools for prolonging one's autonomy. The notions of personality and biographical identity are used to analyze the ethically relevant features. Thereby, it is shown that these concepts are operative in and useful for thinking in biomedical ethics. The overall conclusion is that categorical arguments against precedent autonomy or "Ulysses contracts" are based on misleading theories of personal identity and that advance directives are an ethically respectable tool for prolonging individuals' autonomy in cases of dementia and mental illness.

Entities:  

Keywords:  Analytical Approach; Death and Euthanasia; Philosophical Approach

Mesh:

Year:  1999        PMID: 11657917     DOI: 10.1353/ken.1999.0028

Source DB:  PubMed          Journal:  Kennedy Inst Ethics J        ISSN: 1054-6863


  4 in total

Review 1.  The validity of contracts to dispose of frozen embryos.

Authors:  G Pennings
Journal:  J Med Ethics       Date:  2002-10       Impact factor: 2.903

2.  Ulysses arrangements in psychiatric treatment: towards proposals for their use based on 'sharing' legal capacity.

Authors:  Phil Bielby
Journal:  Health Care Anal       Date:  2014-06

3.  Implant ethics.

Authors:  S O Hansson
Journal:  J Med Ethics       Date:  2005-09       Impact factor: 2.903

4.  Identity change and informed consent.

Authors:  Karsten Witt
Journal:  J Med Ethics       Date:  2017-03-20       Impact factor: 2.903

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.